New hope for kids with Tough-to-Treat neuroblastoma?
NCT ID NCT04106219
First seen Apr 23, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-stage study tests a new drug called LY3295668 erbumine in children whose neuroblastoma has come back or not responded to treatment. The main goal is to see if the drug is safe and to find the best dose. About 71 participants will take the drug alone or with other medicines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alder Hey Children's Hospital
Liverpool, L14 5AB, United Kingdom
-
Centre Leon Berard
Lyon, Auvergne-Rhône-Alpes, 69373 CEDEX 08, France
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Hospital Infantil Universitario Niño Jesús
Madrid, 28009, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [Barcelona], 8035, Spain
-
Institut Curie
Paris, 75248, France
-
Istituto Nazionale dei Tumori
Milan, Lombardy, 20133, Italy
-
National Cancer Center Hospital
Chuo-ku, Tokyo, 104-0045, Japan
-
Perth Children's Hospital
Perth, Western Australia, 6009, Australia
-
Texas Childrens Hospital
Houston, Texas, 77030, United States
-
UCSF Medical Center at Mission Bay
San Francisco, California, 94158, United States
-
UZ Gent
Ghent, Oost-Vlaanderen, 9000, Belgium
-
University of Chicago - Comer Children's Hospital
Chicago, Illinois, 60637, United States
-
Universitätsklinikum Köln
Cologne, 50924, Germany
Conditions
Explore the condition pages connected to this study.